CENK
LIVE

Serial Number

90036788

Owner

NANTKWEST, INC.

Attorney

Alicia M. Passerin

First Use Date

Mar 17, 2021

Filing Date

Jul 6, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CENK Trademark

Serial Number: 90036788 • Registration: 6950523

CENK is a trademark filed by NANTKWEST, INC. on July 6, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

NANTKWEST, INC. (26 trademarks)

2533 SOUTH COAST HIGHWAY 101 STE. 210
CARDIFF-BY-THE-SEA, CA 920072133

Entity Type: 03

IMMUNITYBIO, INC. (142 trademarks)

3530 JOHN HOPKINS COURT
SAN DIEGO, CA 92121

Entity Type: 03

Trademark Details

Filing Date

July 6, 2020

Registration Date

January 10, 2023

First Use Anywhere

March 17, 2021

First Use in Commerce

March 17, 2021

Published for Opposition

December 8, 2020

Goods & Services

Cells for clinical, medical, veterinary, and therapeutic purposes; cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, veterinary, and therapeutic purposes; therapeutic products derived from cells, namely, natural killer cells, for clinical, medical, veterinary, and therapeutic purposes; therapeutic products derived from cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, veterinary, and therapeutic purposes; Kits comprised of cells, reagents and related instructions, for clinical, medicinal, veterinary, and therapeutic purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, veterinary, and therapeutic purposes

Cells for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; cell-derived preparations, namely, natural killer cell-derived preparations, for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; Kits comprised of cells, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes

Providing information relating to clinical, medicinal, and therapeutic properties of cells and cell-derived preparations

Filing History

EXPARTE APPEAL TERMINATED
Jan 10, 2023 EXPT
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 10, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 10, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 3, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 2, 2022 CNPR
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Oct 26, 2022 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Oct 26, 2022 GECD
SU - ACTION CONTINUING FINAL - WRITTEN
Oct 26, 2022 CNCF
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Aug 29, 2022 JURT
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Aug 15, 2022 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Aug 15, 2022 GECD
SU - ACTION CONTINUING FINAL - WRITTEN
Aug 15, 2022 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 20, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 20, 2022 CRFA
ASSIGNED TO LIE
Jul 20, 2022 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 19, 2022 ERFR
EX PARTE APPEAL-INSTITUTED
Jul 19, 2022 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jul 19, 2022 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jul 19, 2022 EXAF
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Apr 6, 2022 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Apr 6, 2022 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Apr 6, 2022 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 16, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 16, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 16, 2022 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 19, 2022 GNFN
FINAL REFUSAL E-MAILED
Jan 19, 2022 GNFR
SU - FINAL REFUSAL - WRITTEN
Jan 19, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 10, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 10, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 2, 2021 TROA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 9, 2021 ASGN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 3, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jun 3, 2021 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jun 3, 2021 CNRT
DATA MODIFICATION COMPLETED
May 21, 2021 DMCC
ASSIGNED TO LIE
May 20, 2021 ALIE
STATEMENT OF USE PROCESSING COMPLETE
May 18, 2021 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 17, 2021 AITU
USE AMENDMENT FILED
May 6, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
May 6, 2021 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 2, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 8, 2020 NPUB
PUBLISHED FOR OPPOSITION
Dec 8, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 18, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 5, 2020 CNSA
ASSIGNED TO EXAMINER
Oct 14, 2020 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Sep 8, 2020 AMPX
ASSIGNED TO LIE
Sep 5, 2020 ALIE
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 17, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 17, 2020 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 17, 2020 COAR
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 17, 2020 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 31, 2020 NWOS
NEW APPLICATION ENTERED
Jul 9, 2020 NWAP